Objective
Cells of the myeloid lineage are the major cellular component of the innate immune system. They orchestrate the adaptive immune response and play a major role in inflammatory pathologies and tumour progression. Given these facts, a more thorough understanding of the control of myeloid cell function is clearly warranted.
Our proposal aims to address this problem directly, by investigating a newly identified family of myeloid receptors. This family is orthologous to a previously identified human receptor, CMRF-35A, and we have thus named them CMRF-35 like molecules (CLM). CLMs are expressed predominantly by myeloid cells.
Our initial studies have been focused on one receptor, CLM-1 and suggest that CLM-1 can block osteoclastogenesis at an intermediate stage of differentiation. Because of the evident and implied importance of this receptor family in the regulation of myeloid cells, I am interested in pursuing studies of their function.
The studies will be focussed in the following areas:
- Complete definition of the CLM receptor family. Initial studies will focus on a more thorough definition of the receptor family in terms of cell and tissue expression.
- Signal transduction studies. We will first attempt to define proteins associating with select CL M receptors, and will use cytoplasmic domain mutants to further delineate signalling pathways engaged by these receptors.
- Ligand identification. A key to determining receptor function is identification of the receptor ligands. This is a particularly challenging task, and to increase chance of success we will use a number of novel library-based approaches.
- Functional studies. Even prior to ligand identification, we will use monoclonal antibodies to initiate functional studies of the CLMs. These will be influenced by cell expression, but they are likely to include typical myeloid cell assays.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- natural sciences biological sciences microbiology bacteriology
- natural sciences biological sciences microbiology virology
- natural sciences biological sciences biochemistry biomolecules proteins
- medical and health sciences basic medicine immunology
- medical and health sciences basic medicine pathology
You need to log in or register to use this function
Keywords
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
FP6-2002-MOBILITY-5
See other projects for this call
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Coordinator
OSLO
Norway
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.